Anti-G17 immunogen (formerly Gastrimmune): Began Phase III trial

By WIR Staff | Apr 17, 2000 | 7:00 AM GMT

Aphton Corp. (APHT), Miami, Fla.
Product: Anti-G17 immunogen (formerly

Read the full 91 word article

How to gain access

Continue reading with a
two-week free trial.